Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 120

1.

Aspirin for Primary Prevention of Cardiovascular Disease and Renal Disease Progression in Chronic Kidney Disease Patients: a Multicenter Randomized Clinical Trial (AASER Study).

Goicoechea M, de Vinuesa SG, Quiroga B, Verde E, Bernis C, Morales E, Fernández-Juárez G, de Sequera P, Verdalles U, Delgado R, Torres A, Arroyo D, Abad S, Ortiz A, Luño J.

Cardiovasc Drugs Ther. 2018 Jun;32(3):255-263. doi: 10.1007/s10557-018-6802-1.

PMID:
29943364
2.

Any grade of relative overhydration is associated with long-term mortality in patients with Stages 4 and 5 non-dialysis chronic kidney disease.

Vega A, Abad S, Macías N, Aragoncillo I, García-Prieto A, Linares T, Torres E, Hernández A, Luño J.

Clin Kidney J. 2018 Jun;11(3):372-376. doi: 10.1093/ckj/sfy018. Epub 2018 Mar 28.

3.

Fabry Nephropathy: An Evidence-Based Narrative Review.

Del Pino M, Andrés A, Bernabéu AÁ, de Juan-Rivera J, Fernández E, de Dios García Díaz J, Hernández D, Luño J, Fernández IM, Paniagua J, Posada de la Paz M, Rodríguez-Pérez JC, Santamaría R, Torra R, Ambros JT, Vidau P, Torregrosa JV.

Kidney Blood Press Res. 2018;43(2):406-421. doi: 10.1159/000488121. Epub 2018 Mar 16.

4.

Impact of anticoagulation and platelet antiaggregation on anaemia and haemorragic events in patients with chronic kidney disease stages 3 and 4.

García-Prieto A, Goicoechea M, Linares T, Panizo N, García de Vinuesa MS, Verdalles Ú, Verde E, Pérez de José A, Luño J.

Med Clin (Barc). 2018 Mar 1. pii: S0025-7753(18)30070-8. doi: 10.1016/j.medcli.2018.01.021. [Epub ahead of print] English, Spanish.

PMID:
29503026
5.

The Combination of Beta Blockers and Renin-Angiotensin System Blockers Improves Survival in Incident Hemodialysis Patients: A Propensity-Matched Study.

Luño J, Varas J, Ramos R, Merello I, Aljama P, MartinMalo A, Pascual J, Praga M; ORD Group.

Kidney Int Rep. 2017 Mar 7;2(4):665-675. doi: 10.1016/j.ekir.2017.03.001. eCollection 2017 Jul.

6.

Low dose aspirin increases 15-epi-lipoxin A4 levels in diabetic chronic kidney disease patients.

Goicoechea M, Sanchez-Niño MD, Ortiz A, García de Vinuesa S, Quiroga B, Bernis C, Morales E, Fernández-Juarez G, de Sequera P, Verdalles U, Verde E, Luño J.

Prostaglandins Leukot Essent Fatty Acids. 2017 Oct;125:8-13. doi: 10.1016/j.plefa.2017.08.009. Epub 2017 Aug 24.

PMID:
28987723
7.

Lesinurad: what the nephrologist should know.

Sanchez-Niño MD, Zheng-Lin B, Valiño-Rivas L, Sanz AB, Ramos AM, Luño J, Goicoechea M, Ortiz A.

Clin Kidney J. 2017 Oct;10(5):679-687. doi: 10.1093/ckj/sfx036. Epub 2017 May 26.

8.

Hyperuricemia is associated with progression of chronic kidney disease in patients with reduced functioning kidney mass.

Galán I, Goicoechea M, Quiroga B, Macías N, Santos A, García de Vinuesa MS, Verdalles Ú, Cedeño S, Verde E, Pérez de José A, García A, Luño J.

Nefrologia. 2018 Jan - Feb;38(1):73-78. doi: 10.1016/j.nefro.2017.04.006. Epub 2017 Aug 30. English, Spanish.

9.

Cardiovascular risk prediction in chronic kidney disease patients.

Cedeño Mora S, Goicoechea M, Torres E, Verdalles Ú, Pérez de José A, Verde E, García de Vinuesa S, Luño J.

Nefrologia. 2017 May - Jun;37(3):293-300. doi: 10.1016/j.nefro.2016.10.002. Epub 2017 May 8. English, Spanish.

10.

Effectiveness of direct-acting antivirals in Hepatitis C virus infection in haemodialysis patients.

Abad S, Vega A, Rincón D, Hernández E, Mérida E, Macías N, Muñoz R, Milla M, Luño J, López-Gómez JM.

Nefrologia. 2017 Mar - Apr;37(2):158-163. doi: 10.1016/j.nefro.2016.10.003. Epub 2016 Nov 30. English, Spanish.

11.

New microorganism in catheter-related bacteremia?

Torres Aguilera E, Verde Moreno E, Muñoz P, Valerio M, Luño J.

Nefrologia. 2017 Jan - Feb;37(1):98-100. doi: 10.1016/j.nefro.2016.09.002. Epub 2016 Oct 13. English, Spanish. No abstract available.

12.

Asymptomatic Intradialytic Supraventricular Arrhythmias and Adverse Outcomes in Patients on Hemodialysis.

Verde E, Pérez de Prado A, López-Gómez JM, Quiroga B, Goicoechea M, García-Prieto A, Torres E, Reque J, Luño J.

Clin J Am Soc Nephrol. 2016 Dec 7;11(12):2210-2217. Epub 2016 Oct 3.

13.

Prevalence and characteristics of patients with resistant hypertension and chronic kidney disease.

Verdalles Ú, Goicoechea M, Garcia de Vinuesa S, Quiroga B, Galan I, Verde E, Perez de Jose A, Luño J.

Nefrologia. 2016 Sep - Oct;36(5):523-529. doi: 10.1016/j.nefro.2016.04.003. Epub 2016 Jul 18. English, Spanish.

14.

The effect of some medications given to CKD patients on vitamin D levels.

Yuste C, Quiroga B, de Vinuesa SG, Goicoechea MA, Barraca D, Verdalles U, Luño J.

Nefrologia. 2015;35(2):150-6. doi: 10.1016/j.nefro.2015.05.016. Epub 2015 Jun 23.

15.

Management of resistant hypertension: aldosterone antagonists or intensification of diuretic therapy?

Verdalles U, García de Vinuesa S, Goicoechea M, Macías N, Santos A, Perez de Jose A, Verde E, Yuste C, Luño J.

Nephrology (Carlton). 2015 Aug;20(8):567-71. doi: 10.1111/nep.12475.

PMID:
25818266
16.

Interarm systolic blood pressure as a predictor of cardiovascular events in patients with chronic kidney disease.

Quiroga B, Galán I, García de Vinuesa S, Goicoechea M, Verdalles Ú, Luño J.

Nephrol Dial Transplant. 2015 May;30(5):801-6. doi: 10.1093/ndt/gfv059. Epub 2015 Mar 9.

PMID:
25753805
17.

Allopurinol and progression of CKD and cardiovascular events: long-term follow-up of a randomized clinical trial.

Goicoechea M, Garcia de Vinuesa S, Verdalles U, Verde E, Macias N, Santos A, Pérez de Jose A, Cedeño S, Linares T, Luño J.

Am J Kidney Dis. 2015 Apr;65(4):543-9. doi: 10.1053/j.ajkd.2014.11.016. Epub 2015 Jan 13.

PMID:
25595565
18.

Spanish Society of Nephrology document on KDIGO guidelines for the assessment and treatment of chronic kidney disease.

Gorostidi M, Santamaría R, Alcázar R, Fernández-Fresnedo G, Galcerán JM, Goicoechea M, Oliveras A, Portolés J, Rubio E, Segura J, Aranda P, de Francisco AL, Del Pino MD, Fernández-Vega F, Górriz JL, Luño J, Marín R, Martínez I, Martínez-Castelao A, Orte LM, Quereda C, Rodríguez-Pérez JC, Rodríguez M, Ruilope LM.

Nefrologia. 2014 May 21;34(3):302-16. doi: 10.3265/Nefrologia.pre2014.Feb.12464. Epub 2014 Mar 6. English, Spanish.

19.

Combined angiotensin inhibition in diabetic nephropathy.

Quiroga B, Fernández Juárez G, Luño J.

N Engl J Med. 2014 Feb 20;370(8):777. doi: 10.1056/NEJMc1315504. No abstract available.

PMID:
24552329
20.

Predictive value of superficial cultures to anticipate tunneled hemodialysis catheter-related bloodstream infection.

Bouza E, Rojas L, Guembe M, Marín M, Anaya F, Luño J, López JM, Muñoz P; COCADI Study Group.

Diagn Microbiol Infect Dis. 2014 Mar;78(3):316-9. doi: 10.1016/j.diagmicrobio.2013.12.008. Epub 2013 Dec 17.

PMID:
24428979

Supplemental Content

Loading ...
Support Center